Search Results - LOPEZ, Prema

  • Showing 1 - 5 results of 5
Refine Results
  1. 1
    24-Month Use of Once-Weekly GH, LB03002, in Prepubertal Children With GH Deficiency

    24-Month Use of Once-Weekly GH, LB03002, in Prepubertal Children With GH Deficiency by Khadilkar, Vaman, Radjuk, Klavdia A, Bolshova, Elena, Khadgawat, Rajesh, El Kholy, Mohamed, Desai, Meena, Peterkova, Valentina, Mericq, Veronica, Kratzsch, Jürgen, Siepl, E. Christine, Martin, Dieter, Lopez, Prema, Ji, Hyi-Jeong, Bae, Yoon Ju, Lee, Jin Hwa, Saenger, Paul H

    Get full text
    Items that cite this one
    Article
    Save to List
    Saved in:
  2. 2
    24-Month Use of Once-Weekly GH, LB03002, in Prepubertal Children With GH Deficiency

    24-Month Use of Once-Weekly GH, LB03002, in Prepubertal Children With GH Deficiency by KHADILKAR, Vaman, RADJUK, Klavdia A, MARTIN, Dieter, LOPEZ, Prema, JI, Hyi-Jeong, YOON JU BAE, JIN HWA LEE, SAENGER, Paul H, BOLSHOVA, Elena, KHADGAWAT, Rajesh, MOHAMED EL KHOLY, DESAI, Meena, PETERKOVA, Valentina, MERICQ, Veronica, KRATZSCH, Jürgen, SIEPL, E. Christine

    Get full text
    Article
    Save to List
    Saved in:
  3. 3
    Higher-Dose Fluvoxamine and Time to Sustained Recovery in Outpatients With COVID-19: The ACTIV-6 Randomized Clinical Trial

    Higher-Dose Fluvoxamine and Time to Sustained Recovery in Outpatients With COVID-19: The ACTIV-6 Randomized Clinical Trial by Stewart, Thomas G, Rebolledo, Paulina A, Mourad, Ahmad, Lindsell, Christopher J, Boulware, David R, McCarthy, Matthew W, Thicklin, Florence, Garcia del Sol, Idania T, Bramante, Carolyn T, Lenert, Leslie A, Lim, Stephen, Williamson, John C, Cardona, Orlando Quintero, Scott, Jake, Schwasinger-Schmidt, Tiffany, Ginde, Adit A, Castro, Mario, Jayaweera, Dushyantha, Sulkowski, Mark, Gentile, Nina, McTigue, Kathleen, Felker, G. Michael, DeLong, Allison, Wilder, Rhonda, Rothman, Russell L, Collins, Sean, Dunsmore, Sarah E, Adam, Stacey J, Hanna, George J, Shenkman, Elizabeth, Hernandez, Adrian F, Naggie, Susanna

    Get full text
    Items that this one cites
    Article
    Save to List
    Saved in:
  4. 4
    Month-6 primary outcomes of the READ-3 study (Ranibizumab for Edema of the mAcula in Diabetes—Protocol 3 with high dose)

    Month-6 primary outcomes of the READ-3 study (Ranibizumab for Edema of the mAcula in Diabetes—Protocol 3 with high dose) by Do, D V, Sepah, Y J, Boyer, D, Callanan, D, Gallemore, R, Bennett, M, Marcus, D M, Halperin, L, Sadiq, M A, Rajagopalan, N, Campochiaro, P A, Nguyen, Q D

    Published in Eye (London)
    Get full text
    Items that this one cites
    Items that cite this one
    Article
    Save to List
    Saved in:
  5. 5
    Time to Sustained Recovery Among Outpatients With COVID-19 Receiving Montelukast vs Placebo: The ACTIV-6 Randomized Clinical Trial

    Time to Sustained Recovery Among Outpatients With COVID-19 Receiving Montelukast vs Placebo: The ACTIV-6 Randomized Clinical Trial by Rothman, Russell L, Stewart, Thomas G, Mourad, Ahmad, Boulware, David R, McCarthy, Matthew W, Thicklin, Florence, Garcia Del Sol, Idania T, Garcia, Jose Luis, Bramante, Carolyn T, Shah, Nirav S, Singh, Upinder, Williamson, John C, Rebolledo, Paulina A, Jagannathan, Prasanna, Schwasinger-Schmidt, Tiffany, Ginde, Adit A, Castro, Mario, Jayaweera, Dushyantha, Sulkowski, Mark, Gentile, Nina, McTigue, Kathleen, Felker, G Michael, DeLong, Allison, Wilder, Rhonda, Collins, Sean, Dunsmore, Sarah E, Adam, Stacey J, Hanna, George J, Shenkman, Elizabeth, Hernandez, Adrian F, Naggie, Susanna, Lindsell, Christopher J

    Published in JAMA network open
    Get full text
    Items that this one cites
    Article
    Save to List
    Saved in:

Search Tools: